Muscle strengthening vs control
Adverse events · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted1 study · 10 participantsGRADE not reported
Findings
What do systematic reviews say?
1,139 questions · 1,173 findings · 89 reviews · Neuromuscular
No studies found 302 · 25.7%GRADE not reported 119 · 10.1%Very low 267 · 22.8%Low 239 · 20.4%Moderate 177 · 15.1%High 69 · 5.9%
Rehabilitation in cold climate vs usual care
Activity limitations 3 months post‐treatment · people with postpolio syndrome
2 findings from 1 review
- no estimate extracted1 study · 53 participantsLow
- no estimate extracted1 study · 53 participantsLow
Rehabilitation in cold climate vs usual care
Activity limitations · people with postpolio syndrome
2 findings from 1 review
- no estimate extracted1 study · 53 participantsLow
- no estimate extracted1 study · 53 participantsLow
Rehabilitation in cold climate vs usual care
Adverse events ‐ not measured · people with postpolio syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Rehabilitation in warm climate vs usual care
Activity limitations 3 months post‐treatment · people with postpolio syndrome
2 findings from 1 review
- no estimate extracted1 study · 57 participantsLow
- no estimate extracted1 study · 57 participantsLow
Rehabilitation in warm climate vs usual care
Adverse events ‐ not measured · people with postpolio syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Static magnetic fields vs placebo
Activity limitations ‐ not measured · people with postpolio syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Static magnetic fields vs placebo
Adverse events · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted1 study · 50 participantsGRADE not reported
IVIg vs placebo
Adverse events · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted3 studies · 212 participantsGRADE not reported
Modafinil vs placebo
Activity limitations · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted1 study · 33 participantsHigh
Modafinil vs placebo
Adverse events · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted2 studies · 50 participantsGRADE not reported
Pyridostigmine vs placebo
Change in activity limitations · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted1 study · 124 participantsModerate
Pyridostigmine vs placebo
Adverse events · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted2 studies · 193 participantsGRADE not reported
Lamotrigine vs control
Activity limitations · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted1 study · 30 participantsVery low
Lamotrigine vs control
Adverse events · people with postpolio syndrome
1 finding from 1 review
- no estimate extracted1 study · 30 participantsGRADE not reported
Gabapentin vs placebo
Participant‐reported pain relief of 50% or greater · patients with pain in Guillain‐Barré syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological treatment for pain in Guillain‐Barré syndrome 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Carbamazepine vs placebo
Rescue analgesic consumption · patients with pain in Guillain‐Barré syndrome
It is very uncertain whether carbamazepine changes rescue analgesic consumption compared with placebo (very low certainty).
1 finding from 1 review
- Pharmacological treatment for pain in Guillain‐Barré syndrome 2015 · Cochrane Headline outcomes onlyno estimate extracted1 study · 24 participantsVery low
Summary of findings table ‐ Methylprednisolone vs placebo
Participant‐reported pain relief of 50% or greater · patients with pain in Guillain‐Barré syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological treatment for pain in Guillain‐Barré syndrome 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Methylprednisolone vs placebo
Number of participants with pain after 4 weeks · patients with pain in Guillain‐Barré syndrome
Methylprednisolone showed no clear difference in number of participants with pain after 4 weeks compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological treatment for pain in Guillain‐Barré syndrome 2015 · Cochrane Headline outcomes onlyRR 0.89 [0.68, 1.16]1 study · 223 participantsLow
Summary of findings table ‐ Methylprednisolone vs placebo
Number of participants with decreased pain after 4 weeks · patients with pain in Guillain‐Barré syndrome
Methylprednisolone showed no clear difference in number of participants with decreased pain after 4 weeks compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological treatment for pain in Guillain‐Barré syndrome 2015 · Cochrane Headline outcomes onlyRR 0.95 [0.63, 1.42]1 study · 223 participantsLow